Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
From the leaves of the Stevia rebaudiana plant originating in Paraguay several glycosides are obtained (rebaudiosides A, B, C, D and E, stevioside and dulcoside) which are used as a substitute for sugar.
The different glycosides are metabolized to steviol (Purkayastha 2016, Wheeler 2008).
It is a non-caloric sweetener, around 300 times sweeter than sucrose (Vargas 2012).
It has been commonly used in South America for centuries and in Japan and China for decades. It is used in traditional medicine with no proven scientific data on its effect on hypertension or hyperglycemia (Ulbricht 2010).
Devoid of toxicity (Gens 2003) at the dose of one or two cups of infusion daily. Maximum intake of steviol: 4 mg per Kg of weight per day.
Steviol glycosides are not genotoxic or carcinogenic (Urban 2013).
Since the last update we have not found published data on its excretion in breastmilk.
Given its lack of toxicity at correct doses, moderate consumption would be compatible with breastfeeding.